Posts in: books

📚 Finished reading: Breakfast of Champions by Kurt Vonnegut, which I had first read 20-some years ago and found merely amusing. Well, Vonnegut was in his late 40s and I turn 42 next month, and I found the entire thing more than just amusing this time around. Listen:

And here, according to Trout, was the reason human beings could not reject ideas because they were bad: “Ideas on Earth were badges of friendship or enmity. Their content did not matter. Friends agreed with friends, in order to express friendliness. Enemies disagreed with enemies, in order to express enmity. “The ideas Earthlings held didn’t matter for hundreds of thousands of years, since they couldn’t do much about them anyway. Ideas might as well be badges as anything. “They even had a saying about the futility of ideas: ‘If wishes were horses, beggars would ride.’ “And then Earthlings discovered tools. Suddenly agreeing with friends could be a form of suicide or worse. But agreements went on, not for the sake of common sense or decency or self-preservation, but for friendliness. “Earthlings went on being friendly, when they should have been thinking instead. And even when they built computers to do some thinking for them, they designed them not so much for wisdom as for friendliness. So they were doomed. Homicidal beggars could ride.

Ain’t that the truth…


📚 Finished reading: "The Billion-Dollar Molecule" by Barry Werth

The Billion-Dollar Molecule tells the story of the late 1980s and early ’90s world of biotech. The only change since then has been that Well, there is one more difference. One billion United States dollars in September 1989 is 2.5 billion of 2025’s USD. one no longer faxes a manuscript and sends supplemental materials by snail mail when submitting to the journal; the personalities, incentives, tradeoffs and challenges are all the same.

Also typical of biotech, and sobering, is that 95% of industry-led research Werth described in the book did not matter: for all the lofty ideals of rational drug design espoused at road shows in investor slide decks, Vertex would chase one fad after another hoping for a hit. Once it got one, a truly life-changing set of drugs for cystic fibrosis, it had burned through so much money and became so profit-driven that it actively blocked low and medium-income countries from developing generic versions. Score for big pharma, which has no qualms about giving away drugs where they are needed.

The story was engrossing enough for me to tolerate Werth’s pulpy writing style, full of adjectives for tortured scientists and smoke-filled rooms. One could easily imagine it serialized on Netflix with distinct chapters, and it had indeed been shopped around, apparently without success. That last link ends with a side note that a movie about Theranos was also planned, and the juxtaposition is apt: more than once Werth notes the dramatic discrepancy between what Vertex management tells investors and the ground truth in the labs. There is certainly a difference between the sociopathy of Elizabeth Holmes and the goings on at your typical fly-by-the-seat-of-your-pants private startup, just not as large as you may think. This is, after all, why most of them go bust.


If you liked Ted Gioia’s reminiscence of David Foster Wallace that I linked to yesterday, you will love Gioia’s follow-up post with recommendations on where to start if you would like to read DFW’s work. To this I would add a plug for The End of the Tour (2015) which is now on my to-watch pile.


There is much to learn from Alan Jacobs’s brief post about the pleasures of reading, if you don’t take it too seriously. Who apologizes for re-reading? Where is the line between keeping count of books read and surveying what you have read in a year? And of course, if after a long day at the office and sharing some evening time with the family the only way to get to a book is to crack it open at 10pm while lying in bed and at least try to read, who is Jacobs (and who am I) to judge? We can’t all be humanities professors.


📚 Finished reading: The Occasional Human Sacrifice by Carl Elliott

The Occasional Human Sacrifice puts faces, personalities, anxieties and neuroses to the names of people who acted as whistleblowers to some of the biggest ethical failures in clinical trials. Some are textbook, like Tuskegee or the Willowbrook hepatitis studies, but many were either new to me, or just barely registered when they were briefly covered.

Elliott was himself a whistleblower in the case of Dan Markingson so he is hardly impartial to their cause — caveat lector — but the cases presented seem truly egregious. And not all of them are ancient history: Paolo Machiarrini experimented on humans without oversight as recently as 2014.

The picture you get is bleak and does not fill one with confidence about clinical research anywhere in the world. Physician-scientists are careless at best, selfish profiteers at worst, people who sit on ethics committees are a bunch of box-checkers, institutions are insular and protective of their own. Of course, there is major selection bias going on: yes, institutions protect their own but then there are many of their members who are accused daily of misconduct by conspiracy theorists, biopharma lobbyists, and the occasional psychopath. Some IRBs are indeed approval mills, but then there are those which truly protect research subjects, though alas what they do doesn’t make it into a book. How to tell where the equilibrium should lie?

In fairness to the book, it does not pretend to be a grand unifying theory of what is wrong with medical research. It is a collection of vignettes, no more and no less, and as such is an important source of “real-world” information to the research community. It is also a big honking red flag to any person thinking to blow the whistle on wrongdoings medical or not: it is a difficult path to take, with no vindication at the end.


Tuesday links (actual hyperlinks included)

Note: While these link posts are usually untitled, this one is in reference to recent troubles at the Marginal Revolution blog. Isn’t HTML great?


📚 Finished reading: In the Beginning… Was the Command Line by Neal Stephenson, almost thirty years old and more relevant than ever. Download it for free here, and if you think you don’t have time for all 65 pages Chapter 12 about the Hole Hawg should motivate you to read the entire essay.


📚 In response to Nassim Taleb’s list, here are 10 writers whose books I’ve read five or more of:

  1. Agatha Christie
  2. CS Lewis
  3. JRR Tolkien
  4. M. John Harrison
  5. Kurt Vonnegut
  6. Neil Gaiman
  7. JK Rowling
  8. Charles Dickens
  9. Arthur Conan Doyle
  10. Taleb himself (who is, I now realize, the odd one out here)

📚 Finished reading: Babel by R. F. Kuang. It has a simple world-building conceit, an ending that announces itself from the very title, and fully Hamiltonified (or is it Bridgertonified?) characters. And yet I couldn’t put the 500-plus pages away, because in an alternate but extremely adjacent universe I went off to study languages instead of medicine as I still eat up anything etymology-related.

Of course, had I known a month ago what I know now I would have taken up Jonathan Strange & Mr Norrell for a re-read instead: it is a deeper, more thoughtful, and infinitely more interesting take on magic in 19th century England. No powerful messages on colonizers and colonized there, sadly, but those I regularly get elsewhere.


📚 Finished reading: Thinking With Tinderbox by Mark Bernstein, after starting two months ago. It is broader in scope and less Tinderbox-specific than The Tinderbox Way, his first book about, well, Tinderbox, a lovingly crafted “tool for thinking” that I have been using off and on for the last seven years. This is for the best: The Tinderbox Way was meant to convert the technical language from the official code reference into something us muggles can use, which is a job that ChatGPT can do much better and using the latest version of the app. Thinking With Tinderbox is more strategic than tactical, elaborating on why anyone whose primary job is not programming would want to dabble in code in the first place.